About Us

Weight Loss Provider Guide is an independent resource helping people find safe, affordable GLP-1 medication providers.

Our Mission

We created Weight Loss Provider Guide to cut through the confusion surrounding GLP-1 weight loss medications. With dozens of telehealth providers now offering semaglutide and tirzepatide, it can be overwhelming to determine which services are legitimate, fairly priced, and right for your needs.

What We Do

Our team researches and compares GLP-1 medication providers based on objective criteria: pricing transparency, medical oversight quality, pharmacy verification, shipping speed, and cancellation policies. We present this information in clear, actionable comparisons so you can make an informed decision.

Who We Are

Editorial Team

Sarah Mitchell — Editor & Lead Researcher

Sarah has spent over 8 years in health and wellness publishing, with a focus on making complex medical topics accessible to consumers. She leads our research methodology, verifies provider claims, and ensures all content meets our editorial standards. Sarah holds a B.S. in Health Communication from Boston University.

Our content is informational and intended to help you understand your options. We are not licensed healthcare providers, and nothing on this site constitutes medical advice. All medical decisions should be made in consultation with your physician.

Our Values

  • Transparency — We clearly disclose our affiliate relationships and explain how we make money.
  • Accuracy — We verify all pricing and provider information regularly and update our comparisons when things change.
  • Safety First — We only feature providers that work with licensed physicians and verified pharmacies.
  • No Hype — We don't make exaggerated claims about weight loss or use pressure tactics to drive clicks.

About Compounded Medications

Some providers we compare offer compounded semaglutide or tirzepatide. It is important to understand that compounded medications are not FDA-approved products. While compounding pharmacies (503A and 503B) are regulated, the specific compounded formulations have not undergone FDA review for safety and efficacy. The FDA has published guidance and safety concerns regarding compounded GLP-1 medications that consumers should review.

Important Note

Weight Loss Provider Guide provides informational content only. We are not healthcare providers, and nothing on this site constitutes medical advice. Always consult with a qualified healthcare professional before starting any medication, including GLP-1 agonists.